Valdez-Haro A, Valle Y, Valdes-Alvarado E, Casillas-Muñoz F, Muñoz-Valle J F, Reynoso-Villalpando G L, Flores-Salinas H E, Padilla-Gutiérrez J R
Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, , , México.
Post-Graduation en Genética Humana, Centro Universitario de Ciencias de la Salud, , , México.
Genet Mol Res. 2017 Sep 27;16(3):gmr-16-03-gmr.16039779. doi: 10.4238/gmr16039779.
Acute coronary syndrome (ACS) is considered one of the main causes of death worldwide. Contradictory findings concerning the impact of the angiotensin-converting enzyme (ACE) gene on cardiovascular diseases have been reported. Previous conclusions point out that the variability in results depends on ethnicity and genetic polymorphisms to determine the association of rs4340 polymorphisms of the ACE gene and ACE circulating levels in ACS. Genotyping of rs4340 polymorphisms was performed in a total of 600 individuals from Western Mexico divided into two groups: the ACS and the control group (CG). The polymorphisms were identified by polymerase chain reaction. Serum ACE concentration was determined by enzyme-linked immunosorbent assay. D/D carriers had higher ACE levels than I/I carriers (3.6 vs 2.8 ng/mL, P < 0.0021) in the CG. The D/D genotype of the rs4340 polymorphism is associated with higher ACE concentration levels; however, the polymorphism was not associated with ACS.